FDA Import Refusal 799-0897038-4/11/5 — PHARMALIFE
The FDA refused shipment 799-0897038-4/11/5 from PHARMALIFE (Mexico) on Jun 9, 2017. The refused product falls under Drugs and Biologics — NAPROXEN SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 9, 2017
- Country
- Mexico
- Product Category
- Drugs and Biologics
- Product Code
- 62GCA50 NAPROXEN SODIUM (ANTI-INFLAMMATORY)
- Charges
- 75